MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-30-2025
AtriCure Total Assets 2011-2025 | ATRC
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets AtriCure
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 609 M | 614 M | 585 M | 615 M | 715 M | 558 M | 357 M | 268 M | 276 M | 273 M | 158 M | 112 M | 32.4 M | 33.9 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 715 M | 32.4 M | 372 M |
Quarterly Total Assets AtriCure
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 609 M | 592 M | 609 M | 615 M | 597 M | 592 M | 614 M | 600 M | 594 M | 583 M | 585 M | 582 M | - | 585 M | 615 M | 613 M | 701 M | 700 M | 715 M | 715 M | 715 M | 715 M | 558 M | 558 M | 558 M | 558 M | 357 M | 357 M | 357 M | 357 M | 268 M | 268 M | 268 M | 268 M | 276 M | 276 M | 276 M | 276 M | 273 M | 273 M | 273 M | 273 M | 158 M | 158 M | 158 M | 158 M | 112 M | 112 M | 112 M | 112 M | 32.4 M | 32.4 M | 32.4 M | 32.4 M | 33.9 M | 33.9 M | 33.9 M | 33.9 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 715 M | 32.4 M | 378 M |
Total Assets of other stocks in the Medical instruments industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Baxter International
BAX
|
25.8 B | $ 19.11 | 0.95 % | $ 9.75 B |  USA |
 |
Becton, Dickinson and Company
BDX
|
55.3 B | $ 196.12 | 0.23 % | $ 56.4 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
26.7 M | $ 5.47 | 3.01 % | $ 110 M | USA |
 |
Luminex Corporation
LMNX
|
825 M | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
10.9 M | - | -9.52 % | $ 20.6 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
213 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
2.07 B | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
192 M | - | - | $ 282 M | USA |
 |
Isoray
ISR
|
341 M | - | 0.03 % | $ 108 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
4.67 B | - | -0.05 % | $ 10.3 B | USA |
 |
iRhythm Technologies
IRTC
|
931 M | $ 175.8 | -1.49 % | $ 5.48 B | USA |
 |
Harvard Bioscience
HBIO
|
137 M | $ 0.73 | 0.64 % | $ 31 M | USA |
 |
Repro Med Systems
KRMD
|
28.5 M | $ 6.48 | -0.61 % | $ 295 M | USA |
 |
Varian Medical Systems, Inc.
VAR
|
4.46 B | - | -0.02 % | $ 16.3 B | USA |
 |
LeMaitre Vascular
LMAT
|
552 M | $ 84.34 | 0.44 % | $ 1.89 B | USA |
 |
ICU Medical
ICUI
|
4.2 B | $ 146.98 | -0.35 % | $ 3.58 B | USA |
 |
Alcon
ALC
|
30.3 B | $ 80.17 | 0.06 % | $ 40.4 B |  Schweiz |
 |
Merit Medical Systems
MMSI
|
2.42 B | $ 87.39 | -0.27 % | $ 5.09 B | USA |
 |
Atrion Corporation
ATRI
|
261 K | - | - | $ 810 M | USA |
 |
electroCore
ECOR
|
16.1 M | $ 4.86 | 1.25 % | $ 26.8 K | USA |
 |
AngioDynamics
ANGO
|
280 M | $ 13.16 | - | $ 538 M | USA |
 |
The Cooper Companies
COO
|
12.4 B | $ 82.57 | -0.37 % | $ 16.4 B | USA |
 |
Glaukos Corporation
GKOS
|
940 M | $ 116.64 | 0.4 % | $ 5.65 B | USA |
 |
Masimo Corporation
MASI
|
2.63 B | $ 133.28 | -0.44 % | $ 7.1 B | USA |
 |
Haemonetics Corporation
HAE
|
2.45 B | $ 80.01 | -0.44 % | $ 4.03 B | USA |
 |
InfuSystem Holdings
INFU
|
99.4 M | $ 9.11 | 0.66 % | $ 188 M | USA |
 |
Predictive Oncology
POAI
|
4.97 M | - | - | $ 32.4 M | USA |
 |
Intuitive Surgical
ISRG
|
18.7 B | $ 577.15 | -0.03 % | $ 205 B | USA |
 |
OraSure Technologies
OSUR
|
480 M | $ 2.43 | 2.53 % | $ 181 M | USA |
 |
Microbot Medical
MBOT
|
8.33 M | $ 2.18 | - | $ 22.2 M |  Israel |
 |
STERIS plc
STE
|
10.1 B | $ 255.68 | 0.11 % | $ 25.2 B | USA |
 |
Stereotaxis
STXS
|
41.9 M | $ 2.43 | -0.82 % | $ 196 M | USA |
 |
Milestone Scientific
MLSS
|
9.8 M | $ 0.29 | -0.48 % | $ 23.1 M | USA |
 |
Nephros
NEPH
|
11.9 M | $ 5.23 | 12.23 % | $ 54.3 M | USA |
 |
NeuroMetrix
NURO
|
15.3 M | - | 5.05 % | $ 9.02 M | USA |
 |
Envista Holdings Corporation
NVST
|
5.35 B | $ 22.0 | 0.59 % | $ 3.79 B | USA |
 |
ResMed
RMD
|
5.1 B | $ 244.44 | -0.07 % | $ 35.7 B | USA |
 |
Pro-Dex
PDEX
|
61.2 M | $ 40.4 | -2.38 % | $ 133 M | USA |
 |
Pulse Biosciences
PLSE
|
59.2 M | $ 14.86 | 1.92 % | $ 714 M | USA |
 |
Utah Medical Products
UTMD
|
135 M | $ 56.29 | -1.14 % | $ 204 M | USA |
 |
Repligen Corporation
RGEN
|
2.83 B | $ 165.66 | -0.42 % | $ 9.23 M | USA |
 |
DENTSPLY SIRONA
XRAY
|
5.75 B | $ 11.22 | 1.26 % | $ 2.28 B | USA |
 |
BioLife Solutions
BLFS
|
399 M | $ 25.41 | -0.2 % | $ 1.17 B | USA |
 |
STAAR Surgical Company
STAA
|
510 M | $ 23.63 | -1.25 % | $ 1.16 B | USA |
 |
Retractable Technologies
RVP
|
161 M | $ 0.82 | 0.22 % | $ 24.5 M | USA |
 |
Teleflex Incorporated
TFX
|
7.1 B | $ 122.33 | 0.03 % | $ 5.73 B | USA |
 |
West Pharmaceutical Services
WST
|
3.64 B | $ 276.66 | -0.3 % | $ 20.2 B | USA |